the aid library

LIST OPTIONS

Filter

2567

Cholera in Yemen: A case study of epidemic preparedness and response

The Johns Hopkins Center for Humanitarian Healt (2018) C1

The report offers 20 top recommendations for getting ahead of future outbreaks in Yemen and similarly complex humanitarian settings. In 2015, Yemen was declared a Level 3 emergency by the UN, kicking into gear the highest level of humanitarian support. A massive cholera outbreak followed, leading t... more

Download (412)

View PDF (691)

Clinical management of COVID-19: Living guideline, 15 September 2022
recommended

World Health Organization WHO (2022) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ... more

Download (551)

View PDF (1042)

Emerging El Niño Conditions: Notes for the Global Health Community

International Research Institute for Climate and Society, World Health Organization (2014) C_WHO

Download (387)

View PDF (394)

Standard treatment guidelines oncology India

Ministry of Health & Family Welfare, India (2020) C1

Accessed Febr. 6, 2020

Download (293)

View PDF (379)

Ambient air pollution and non-communicable respiratory illness in sub-Saharan Africa: a systematic review of the literature

Glenn, B. E.; Espira, L. M.; Larson, M. C.; Larson, P. S. BMC (2022) CC2

Aerosol pollutants are known to raise the risk of development of non-communicable respiratory diseases (NCRDs) such as asthma, chronic bronchitis, chronic obstructive pulmonary disease, and allergic rhinitis. Sub-Saharan Africa’s rapid pace of urbanization, economic expansion, and population growt... more

Download (505)

View PDF (443)

Suicide and self-harming behaviour

T. Jans; T. D. Vloet; Y. Taneli; A. Warnke IACAPAP (2018) C2

Mood disorders Chapter E.4 2018 edition

External Link

WHO Model Formulary for Children
recommended

World Health Organization WHO (2010) C_WHO

WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009. In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,... more

Download (214)

View PDF (333)

Health Workers Training Guide for Managing Female Genital Schistosomiasis (FGS) in Primary Health Care

Countdown Calling Time on Neglected Tropical Diseases Sightsavers (2021) CC

This trainer toolkit is a guide for Neglected Tropical Diseases (NTD) program implementers in Nigeria to train primary health care health workers to diagnose and provide care for women and girls with symptoms of female genital schistosomiasis (FGS). It has been developed based on a pilot study in ... more

Download (489)

View PDF (636)

Papua New Guinea: Disaster Management Reference Handbook

Center for Excellence in Disaster Management and Humanitarian Assistance (2016) C1

The 2012 NDRMP lays out the Disaster Risk Management (DRM) architecture of the country and provides guidance for DRM intervention at all levels. However, implementation has been slow and resource challenges exist throughout the government.
The PNG government’s policy and institutional framework... more

Download (4729)

View PDF (5081)

How to Recognise and Manage Leprosy Reactions
recommended

The International Federation of Anti-Leprosy Associations (ILEP) (2002) C1

This book is for all health workers who may have to help people who have nerve damage to their eyes, hands and feet. It will help them to encourage patients to develop a lifetime habit of caring for nerve-damaged parts.

Download (261)

View PDF (429)

The efects of extreme heat on human health in tropical africa

Kunda J., Gosling S., Foody G. et al. (2024) C2

This review examines high-quality research evidence that synthesises the efects of extreme heat on human health in tropical Africa. Web of Science (WoS) was used to identify research articles on the efects extreme heat, humidity, Wet-bulb Globe Temperature (WBGT), apparent temperature, wind, Heat ... more

Download (2006)

View PDF (4334)

First Aid in armed conflicts and other situations of violence

International Committee of the Red Cross ICRC (2006)

A practical manual presenting the specific knowledge, skills and practices that First Aiders should have to act safely and effectively when caring for people caught up in armed conflicts and other situations of violence, such as internal disturbances and tensions.

External Link

World Heart Federation Cholesterol Roadmap 2022

Ray, K.K.; Ference, B.A.; Séverin, T. et al. World Heart Federation (2022) CC

Background: Atherosclerotic cardiovascular diseases (ASCVD) including myocardial infarction, stroke and peripheral arterial disease continue to be major causes of premature death, disability and healthcare expenditure globally. Preventing the accumulation of cholesterol-containing atherogenic lipopr... more

Download (309)

View PDF (502)

Other substance use

W.Cheung; A. K. Lam; S. Hung IACAPAP (2012) C2

Substance use disorders Chapter G.3

External Link

Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study

L. R. Augustemak de Lima; E. L. Petroski; Y. M. F. Moreno; et al. PLOS ONE (2018) CC

Research Article PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018

Download (319)

View PDF (346)

A Cross-Sectional Study of Disclosure of HIV Status to Children and Adolescents in Western Kenya

R. C. Vreeman; M. L. Scanlon; A. Mwangi; et al. PLOS One (2014) CC

PLOS ONE | www.plosone.org 1 January 2014 | Volume 9 | Issue 1 | e86616

Download (517)

View PDF (735)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (720)

View PDF (1265)

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO) (2018) C_WHO

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t... more

Clinical management of COVID-19: Living guideline, 15 September 2022 recommended

WHO Model Formulary for Children recommended

How to Recognise and Manage Leprosy Reactions recommended

Clinical management of COVID-19: Living guideline, 15 September 2022
recommended

WHO Model Formulary for Children
recommended

How to Recognise and Manage Leprosy Reactions
recommended